Target intelligence / Profile preview

Gastric mucosal proteins at ulcerated sites

Molecular classification
Other
01

Overview

Gastric mucosal proteins at ulcerated or damaged sites refer to the proteinaceous exudate, primarily consisting of albumin, fibrinogen, and globulins, that becomes exposed when the gastric lining is breached (StatPearls, NBK551527). In the acidic environment of the stomach, these proteins carry a strong positive charge, making them a unique pharmacological target for cytoprotective agents (PubChem, CID 6398). Drugs like sucralfate undergo polymerization to form a negatively charged, paste-like substance that selectively binds to these exposed proteins (PubMed, 2671365). This interaction creates a physical barrier that shields the damaged tissue from further injury by gastric acid, pepsin, and bile salts, thereby facilitating the natural healing process (NIH, LiverTox). This target is central to the treatment of peptic ulcer disease and various forms of gastritis where mucosal integrity is compromised.

Other names
Ulcer-adherent protein complexExposed mucosal proteinsProteinaceous exudateGastric ulcer base proteins
02

Mechanism of action

Formation of a physical barrier by binding to positively charged proteins (such as albumin and fibrinogen) at the site of mucosal damage, protecting the ulcer from gastric acid, pepsin, and bile salts (StatPearls, NBK551527).

03

Biological functions

Tissue repairMucosal protection
04

Disease associations

InflammationPeptic ulcer diseaseGastritis
05

Safety considerations

Aluminum accumulation in renal impairment (StatPearls, NBK551527)Constipation (PubChem, CID 6398)Reduced absorption of co-administered drugs (NIH, LiverTox)
06

Interacting drugs

Sucralfate

3 more in the full profile.

07

Biomarkers

Endoscopic ulcer healingGastric mucosal integrity

Beyond the preview

Go deeper on Gastric mucosal proteins at ulcerated sites.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric mucosal proteins at ulcerated sites.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call